| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.02 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |